Four Year Analysis of 28 Million Adults Finds No Mortality Increase From COVID Vaccination
Last updated on
Five years ago, healthcare workers around the world rolled up their sleeves and received an injection that would spark one of modern medicine’s most heated debates. Millions followed in the months ahead, lining up at pharmacies, stadiums, and makeshift clinics to receive their COVID-19 vaccines. Others refused, citing concerns about long-term effects that no one could yet measure. Now, after years of speculation, political battles, and passionate arguments at dinner tables across the globe, researchers have finally gathered enough data to answer the question that has haunted both camps. What actually happened to everyone who received those vaccines? A massive new study published in JAMA Network Open tracked nearly 29 million French adults over four years, making it the largest and longest analysis of COVID-19 vaccine outcomes to date. And the findings may surprise people on both sides of the debate.France Became a Living Laboratory
Mortality Rates Tell an Unexpected Story

Skeptics Raise Valid Questions About Confounding Factors
Critics of vaccine research have long argued that studies fail to account for differences between people who choose vaccination and those who decline. French researchers anticipated these objections and attempted to address them head-on. Vaccinated participants tended to be slightly older, with a mean age of 38 compared to 37.1 for unvaccinated individuals. Women made up 51.3% of the vaccinated group versus 48.5% of the unvaccinated population. More significantly, vaccinated individuals showed higher rates of cardiometabolic conditions, including diabetes, hypertension, and obesity. Yet despite these risk factors that would typically predict higher mortality, vaccinated individuals lived longer on average. Researchers attributed part of this apparent paradox to socioeconomic differences between groups. Vaccinated participants were less likely to receive complementary state health insurance, a program serving lower-income French residents. Only 9.2% of vaccinated individuals used the program compared to 20.9% of unvaccinated participants. Geographic distribution also differed, with unvaccinated individuals more concentrated in overseas territories and southern regions. Scientists used statistical weighting to account for 41 different comorbidities and demographic characteristics. Even after these adjustments, the mortality gap persisted. Researchers then calculated something called an E value, which measures how strong an unmeasured factor would need to be to explain away the observed results. An unmeasured confounder would need to double the risk of either vaccination or death while halving the other to account for the findings.Rare Side Effects Confirmed as Rare

Political Tensions Complicate Scientific Findings

Unanswered Questions Remain

Scientists Draw Clear Conclusions

Pandemic’s Shadow Still Looms
Some of the links I post on this site are affiliate links. If you go through them to make a purchase, I will earn a small commission (at no additional cost to you). However, note that I’m recommending these products because of their quality and that I have good experience using them, not because of the commission to be made.




























JOIN OVER
Comments